Search hospitals > Ohio > Columbus
The Mark H Zangmeister Center
Claim this profileColumbus, Ohio 43219
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Stomach Cancer
275 reported clinical trials
7 medical researchers
Summary
The Mark H Zangmeister Center is a medical facility located in Columbus, Ohio. This center is recognized for care of Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Stomach Cancer and other specialties. The Mark H Zangmeister Center is involved with conducting 275 clinical trials across 404 conditions. There are 7 research doctors associated with this hospital, such as Timothy D. Moore, Jeanna L Knoble, Sameh Mikhail, MD, and Emily Whitman.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center6 years of reported clinical research
Expert in Skin Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
Jeanna L KnobleZangmeister Cancer Center3 years of reported clinical research
Studies Breast Cancer
Studies Uterine Tumors
3 reported clinical trials
11 drugs studied
Sameh Mikhail, MDZangmeister Cancer Center4 years of reported clinical research
Studies Colorectal Cancer
Studies Small Cell Lung Cancer
2 reported clinical trials
3 drugs studied
Emily WhitmanZangmeister Cancer Center5 years of reported clinical research
Studies Fallopian Tube Cancer
Studies Ovarian Cancer
2 reported clinical trials
4 drugs studied
Clinical Trials running at The Mark H Zangmeister Center
Breast Cancer
Lung Cancer
Skin Cancer
Breast cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Bladder Cancer
Cutaneous Melanoma
Uterine Tumors
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Mark H Zangmeister Center?
The Mark H Zangmeister Center is a medical facility located in Columbus, Ohio. This center is recognized for care of Skin Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Stomach Cancer and other specialties. The Mark H Zangmeister Center is involved with conducting 275 clinical trials across 404 conditions. There are 7 research doctors associated with this hospital, such as Timothy D. Moore, Jeanna L Knoble, Sameh Mikhail, MD, and Emily Whitman.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.